Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, announced today that the Genedata Screener User Group will hold its annual knowledge sharing event on May 5, 2009 at the California Academy of Science. Representatives from leading biotechnology companies such as Amgen, Exelixis, and Genentech will preview Screener 7.0 and share industry best practices for high throughput, high content screening methodologies.
“The Screener User Group meeting is a highly interactive session of biotech industry leaders who are provided an under-the-covers look at our Screener 7.0 release combined with the unique opportunity to comment on and influence future product development,” noted Stephan Heyse, head of Screener. “Of equal importance is the knowledge-sharing dimension of this meeting in which our customers present insights on Screener integration, cross-assay comparison, and tips and techniques on conducting high throughput, high content data screening analysis.”
The Screener User Group meeting will be held at the Boardroom of California Academy of Sciences, 55 Music Concourse Dr., Golden Gate Park, San Francisco, CA 94118 415-379-8000; www.calacademy.org. For further information on the Screener User Group meeting, contact: Kurt Zingler, email@example.com
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US. www.genedata.com
Marketing & Communications
Phone: +41 61 511 8459
Phone: +1 508 881 3109
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.